Garrison Bradford & Associates’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.61M | Sell |
7,200
-250
| -3% | -$120K | 3.92% | 10 |
|
|
2026
Q1 | $3.66M | Sell |
7,450
-2,150
| -22% | -$1.17M | 4.14% | 9 |
|
|
2025
Q4 | $5.56M | Sell |
9,600
-525
| -5% | -$297K | 6.04% | 6 |
|
|
2025
Q3 | $4.91M | Sell |
10,125
-230
| -2% | -$107K | 5.25% | 6 |
|
|
2025
Q2 | $4.2M | Hold |
10,355
| – | – | 4.65% | 8 |
|
|
2025
Q1 | $5.15M | Hold |
10,355
| – | – | 5.67% | 7 |
|
|
2024
Q4 | $5.39M | Hold |
10,355
| – | – | 5.64% | 7 |
|
|
2024
Q3 | $6.41M | Sell |
10,355
-545
| -5% | -$323K | 6.35% | 6 |
|
|
2024
Q2 | $6.03M | Sell |
10,900
-780
| -7% | -$447K | 6.19% | 6 |
|
|
2024
Q1 | $6.79M | Sell |
11,680
-107
| -0.9% | -$60K | 7% | 6 |
|
|
2023
Q4 | $6.26M | Sell |
11,787
-80
| -0.7% | -$38.7K | 6.9% | 5 |
|
|
2023
Q3 | $6.01M | Hold |
11,867
| – | – | 7.09% | 5 |
|
|
2023
Q2 | $6.19M | Hold |
11,867
| – | – | 7.48% | 4 |
|
|
2023
Q1 | $6.84M | Hold |
11,867
| – | – | 8.47% | 2 |
|
|
2022
Q4 | $6.54M | Sell |
11,867
-345
| -3% | -$183K | 7.93% | 2 |
|
|
2022
Q3 | $6.19M | Sell |
12,212
-200
| -2% | -$112K | 7.54% | 3 |
|
|
2022
Q2 | $6.74M | Hold |
12,412
| – | – | 7.67% | 2 |
|
|
2022
Q1 | $7.33M | Sell |
12,412
-300
| -2% | -$172K | 7.12% | 4 |
|
|
2021
Q4 | $8.48M | Sell |
12,712
-60
| -0.5% | -$37.5K | 7.61% | 3 |
|
|
2021
Q3 | $7.3M | Hold |
12,772
| – | – | 7.42% | 3 |
|
|
2021
Q2 | $6.44M | Hold |
12,772
| – | – | 6.7% | 3 |
|
|
2021
Q1 | $5.83M | Hold |
12,772
| – | – | 6.5% | 4 |
|
|
2020
Q4 | $5.95M | Sell |
12,772
-628
| -5% | -$294K | 7.25% | 2 |
|
|
2020
Q3 | $5.92M | Hold |
13,400
| – | – | 8.34% | 2 |
|
|
2020
Q2 | $4.86M | Hold |
13,400
| – | – | 7.05% | 2 |
|
|
2020
Q1 | $3.8M | Sell |
13,400
-300
| -2% | -$94.6K | 6.5% | 5 |
|
|
2019
Q4 | $4.45M | Sell |
13,700
-100
| -0.7% | -$30.3K | 5.58% | 5 |
|
|
2019
Q3 | $4.02M | Sell |
13,800
-1,500
| -10% | -$430K | 5.48% | 5 |
|
|
2019
Q2 | $4.49M | Sell |
15,300
-3,650
| -19% | -$1.01M | 5.26% | 4 |
|
|
2019
Q1 | $5.19M | Hold |
18,950
| – | – | 4.4% | 5 |
|
|
2018
Q4 | $4.24M | Hold |
18,950
| – | – | 3.83% | 4 |
|
|
2018
Q3 | $4.63M | Sell |
18,950
-2,000
| -10% | -$460K | 3.73% | 6 |
|
|
2018
Q2 | $4.34M | Hold |
20,950
| – | – | 3.56% | 6 |
|
|
2018
Q1 | $4.33M | Hold |
20,950
| – | – | 3.68% | 6 |
|
|
2017
Q4 | $3.98M | Sell |
20,950
-2,703
| -11% | -$518K | 3.29% | 9 |
|
|
2017
Q3 | $4.47M | Buy |
23,653
+1
| +0% | +$181 | 3.75% | 6 |
|
|
2017
Q2 | $4.13M | Hold |
23,652
| – | – | 3.57% | 6 |
|
|
2017
Q1 | $3.63M | Hold |
23,652
| – | – | 3.21% | 9 |
|
|
2016
Q4 | $3.34M | Buy |
23,652
+1
| +0% | +$147 | 3.08% | 9 |
|
|
2016
Q3 | $3.76M | Hold |
23,651
| – | – | 3.54% | 6 |
|
|
2016
Q2 | $3.5M | Buy |
23,651
+1
| +0% | +$148 | 3.43% | 7 |
|
|
2016
Q1 | $3.35M | Hold |
23,650
| – | – | 3.9% | 6 |
|
|
2015
Q4 | $3.35M | Sell |
23,650
-350
| -1% | -$46.7K | 3.76% | 6 |
|
|
2015
Q3 | $2.94M | Buy |
24,000
+850
| +4% | +$111K | 3.24% | 7 |
|
|
2015
Q2 | $3M | Hold |
23,150
| – | – | 2.93% | 9 |
|
|
2015
Q1 | $3.11M | Hold |
23,150
| – | – | 2.9% | 7 |
|
|
2014
Q4 | $2.9M | Buy |
23,150
+1,000
| +5% | +$122K | 2.63% | 10 |
|
|
2014
Q3 | $2.7M | Sell |
22,150
-300
| -1% | -$36.5K | 2.7% | 11 |
|
|
2014
Q2 | $2.65M | Sell |
22,450
-2,700
| -11% | -$318K | 2.47% | 11 |
|
|
2014
Q1 | $3.02M | Hold |
25,150
| – | – | 2.91% | 8 |
|
|
2013
Q4 | $2.8M | Hold |
25,150
| – | – | 2.65% | 11 |
|
|
2013
Q3 | $2.32M | Hold |
25,150
| – | – | 2.37% | 13 |
|
|
2013
Q2 | $2.13M | Buy |
+25,150
| New | +$2.09M | 2.29% | 13 |
|
Other funds holding TMO
RG
ECSS
LT
ATO
Garrison Bradford & Associates's TMO Position: Q2 2026 in Review
Garrison Bradford & Associates reduced its Thermo Fisher Scientific (TMO) stake by 3.4% in Q2 2026, selling an estimated $120K and leaving 7,200 shares worth $3.61M. The position accounts for 3.92% of the portfolio, ranked #10.
Garrison Bradford & Associates first reported a position in TMO in Q2 2013 and has held it in 53 quarters since. The position peaked at $8.48M in Q4 2021. 1,030 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Garrison Bradford & Associates held 7,200 shares of Thermo Fisher Scientific worth $3.61M as of Q2 2026.
- Garrison Bradford & Associates sold 250 Thermo Fisher Scientific shares in Q2 2026, an estimated $120K.
- Thermo Fisher Scientific made up 3.92% of Garrison Bradford & Associates's portfolio in Q2 2026, its #10 holding.
- Garrison Bradford & Associates first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 53 quarters since.
- Garrison Bradford & Associates's Thermo Fisher Scientific position peaked at $8.48M in Q4 2021.
- 1,030 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Garrison Bradford & Associates's 13F filing for Q2 2026, filed 28 Jul 2026.